BE825653A - Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique - Google Patents

Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique

Info

Publication number
BE825653A
BE825653A BE1006466A BE1006466A BE825653A BE 825653 A BE825653 A BE 825653A BE 1006466 A BE1006466 A BE 1006466A BE 1006466 A BE1006466 A BE 1006466A BE 825653 A BE825653 A BE 825653A
Authority
BE
Belgium
Prior art keywords
phenylace
tamido
cephem
formyloxy
thiomethyl
Prior art date
Application number
BE1006466A
Other languages
English (en)
French (fr)
Inventor
J M Indelicato
J M Greene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23765656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE825653(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BE825653A publication Critical patent/BE825653A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE1006466A 1974-02-22 1975-02-18 Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique BE825653A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US444622A US3928592A (en) 1974-02-22 1974-02-22 Antibiotic pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE825653A true BE825653A (fr) 1975-08-18

Family

ID=23765656

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1006466A BE825653A (fr) 1974-02-22 1975-02-18 Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique

Country Status (24)

Country Link
US (1) US3928592A (fi)
JP (1) JPS6119605B2 (fi)
AR (1) AR203895A1 (fi)
AT (1) AT356264B (fi)
BE (1) BE825653A (fi)
CA (1) CA1043261A (fi)
CH (1) CH620929A5 (fi)
CS (1) CS189689B2 (fi)
DD (1) DD117807A5 (fi)
DE (1) DE2506622A1 (fi)
DK (1) DK153919C (fi)
ES (1) ES434976A1 (fi)
FR (1) FR2261772B1 (fi)
GB (1) GB1493676A (fi)
HU (1) HU174129B (fi)
IE (1) IE40671B1 (fi)
IL (1) IL46650A (fi)
NL (1) NL179976C (fi)
PH (1) PH12058A (fi)
PL (1) PL109311B1 (fi)
SE (1) SE406153B (fi)
SU (1) SU659094A3 (fi)
YU (1) YU41875A (fi)
ZA (1) ZA75975B (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283956A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Antibiotic method and medical composition

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
NZ232763A (en) * 1989-03-06 1991-09-25 Lilly Co Eli Parenteral formulation comprising daptomycin with a buffer to maintain ph between 6.0 and 8.0
JP4873207B2 (ja) * 2001-02-26 2012-02-08 東レ・ファインケミカル株式会社 光学活性カルボン酸クロリドの精製方法
CN100554271C (zh) * 2007-07-27 2009-10-28 苏州中联化学制药有限公司 抗菌素头孢孟多酯钠的合成方法
CN101880290B (zh) * 2010-06-28 2012-03-07 海南新中正制药有限公司 头孢孟多酯钠的制备方法
WO2013057197A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
US9834567B1 (en) * 2014-12-16 2017-12-05 Tianjin University Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283956A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Antibiotic method and medical composition

Also Published As

Publication number Publication date
DE2506622C2 (fi) 1987-02-26
DD117807A5 (fi) 1976-02-05
FR2261772A1 (fi) 1975-09-19
NL179976C (nl) 1986-12-16
NL179976B (nl) 1986-07-16
IL46650A (en) 1977-10-31
ES434976A1 (es) 1976-12-16
YU41875A (en) 1982-05-31
AT356264B (de) 1980-04-25
SU659094A3 (ru) 1979-04-25
ZA75975B (en) 1976-09-29
DE2506622A1 (de) 1975-08-28
ATA128475A (de) 1979-09-15
GB1493676A (en) 1977-11-30
IL46650A0 (en) 1975-05-22
AR203895A1 (es) 1975-10-31
SE406153B (sv) 1979-01-29
CA1043261A (en) 1978-11-28
FR2261772B1 (fi) 1980-01-04
JPS6119605B2 (fi) 1986-05-17
DK65575A (fi) 1975-10-20
IE40671B1 (en) 1979-07-18
NL7502045A (nl) 1975-08-26
CH620929A5 (fi) 1980-12-31
CS189689B2 (en) 1979-04-30
AU7833975A (en) 1976-08-19
DK153919C (da) 1989-02-06
SE7501985L (fi) 1975-08-25
US3928592A (en) 1975-12-23
HU174129B (hu) 1979-11-28
PH12058A (en) 1978-10-18
PL109311B1 (en) 1980-05-31
IE40671L (en) 1975-08-22
JPS50126817A (fi) 1975-10-06
DK153919B (da) 1988-09-26

Similar Documents

Publication Publication Date Title
BE825653A (fr) Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique
BE828555A (fr) Composition pour le traitement d'infections virales
BE814546A (fr) Nouvelles cephalosporines et compositions pharmaceutiques en contenant
BE782366A (fr) Nouveaux derives de l'acide cephalosporanique
BE829344A (fr) Preparation de l'alpha-6-desocy-5- hydroxytetracycline
BE747726A (fr) Preparation d'acide (+ ou -)-trans-chrysanthemique
BE810145A (fr) Nouvelles compositions geriatriques contenant des derives de l'acide theophylline-7-acetique
RO66809A (ro) Diblu de spraituire
FR2301244A1 (fr) Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium
BE815499A (fr) Compositions pharmaceutiques contenant des derives de triazolo-isoquinoleine
BE802356A (fr) Derives de l'acide succinique
IT1014466B (it) Procedimento per la preparazione di percarbonato di sodio
BE786128A (fr) Compositions effervescentes contenant l'ester methylique de l-aspartyl-l-3-phenylalanine
RO73936A (ro) Compozitie de explozivi aposi
FR2287230A1 (fr) Derives de l'acide cephalosporanique
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE837766A (fr) Preparation de derives de l'acide 7-aminocephalosporanique
BR7405891D0 (pt) Preparacao de composicao de dihidrato de dicloroisocianurato de sodio
BE754650A (fr) Preparation d'alcenylalcoxysilanes
BE808969A (fr) Nouveaux derives de l'acide prostanoique
BE796435A (fr) Compositions pharmaceutiques contenant des derives de l'acide benzoique
BE829024A (fr) Compositions pharmaceutiques pour le traitement de l'hydropisie
BE771936A (fr) Preparation d'alpha-dithiols
FR2279739A1 (fr) Preparation d'hexamethyleneimine
FR2315276A1 (fr) Compositions pharmaceutiques contenant des tetrahydroisoquinoleines substituees

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 19950218